173 related articles for article (PubMed ID: 26035378)
61. Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1.
Yang L; Ji J; Chen Z; Wang H; Li J
Neoplasma; 2014; 61(2):193-204. PubMed ID: 24299315
[TBL] [Abstract][Full Text] [Related]
62. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
63. Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model.
Lu JW; Hsia Y; Yang WY; Lin YI; Li CC; Tsai TF; Chang KW; Shieh GS; Tsai SF; Wang HD; Yuh CH
Carcinogenesis; 2012 Jan; 33(1):209-19. PubMed ID: 22021908
[TBL] [Abstract][Full Text] [Related]
64. Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Aziz K; Limzerwala JF; Sturmlechner I; Hurley E; Zhang C; Jeganathan KB; Nelson G; Bronk S; Fierro Velasco RO; van Deursen EJ; O'Brien DR; Kocher JA; Youssef SA; van Ree JH; de Bruin A; van den Bos H; Spierings DCJ; Foijer F; van de Sluis B; Roberts LR; Gores GJ; Li H; van Deursen JM
Gastroenterology; 2019 Jul; 157(1):210-226.e12. PubMed ID: 30878468
[TBL] [Abstract][Full Text] [Related]
65. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
Hulla JE; Chen ZY; Eaton DL
Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
[TBL] [Abstract][Full Text] [Related]
66. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
[TBL] [Abstract][Full Text] [Related]
67. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
68. [Hepatocellular carcinoma: molecular biology aspects].
Blum HE
Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
[TBL] [Abstract][Full Text] [Related]
69. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
Qi LN; Li LQ; Chen YY; Chen ZH; Bai T; Xiang BD; Qin X; Xiao KY; Peng MH; Liu ZM; Liu TW; Qin X; Li S; Han ZG; Mo ZN; Santella RM; Winkler CA; O'Brien SJ; Peng T
PLoS One; 2013; 8(12):e83465. PubMed ID: 24391771
[TBL] [Abstract][Full Text] [Related]
70. [Different gene expression during hepatocarcinogenesis in tree shrew induced by aflatoxin B1].
Li Y; Su JJ; Cao JI; Ou C; Qiu XK; Ban KC; Yang C; Qin LL
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):96-8. PubMed ID: 12648405
[TBL] [Abstract][Full Text] [Related]
71. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
72. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
Murakami Y
Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
[TBL] [Abstract][Full Text] [Related]
73. Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.
Coulouarn C; Factor VM; Conner EA; Thorgeirsson SS
Carcinogenesis; 2011 Oct; 32(10):1434-40. PubMed ID: 21771728
[TBL] [Abstract][Full Text] [Related]
74. A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.
Angioni MM; Bellofatto K; Merlin S; Menegon S; Perra A; Petrelli A; Sulas P; Giordano S; Columbano A; Follenzi A
Oncotarget; 2017 Feb; 8(9):15716-15731. PubMed ID: 28157710
[TBL] [Abstract][Full Text] [Related]
75. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
Oropeza CE; Ondracek CR; Tarnow G; Maienschein-Cline M; Green SJ; McLachlan A
Virology; 2022 Jan; 566():16-25. PubMed ID: 34844082
[TBL] [Abstract][Full Text] [Related]
76. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
77. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways.
Liu Y; Li YQ; Huang SH; Li YL; Xia JW; Jia JS; Wei F; Wang JH; Dai GQ; Wang YC; Li XY; Han LX; Zhang XL; Xiang XD; Zhao WT; Xiao D; Lin XL
Aging (Albany NY); 2021 Sep; 13(17):21155-21190. PubMed ID: 34517344
[TBL] [Abstract][Full Text] [Related]
78. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
[TBL] [Abstract][Full Text] [Related]
79. Hepatocellular carcinoma: an update.
Dominguez-Malagón H; Gaytan-Graham S
Ultrastruct Pathol; 2001; 25(6):497-516. PubMed ID: 11783914
[TBL] [Abstract][Full Text] [Related]
80. Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma.
Kodama T; Bard-Chapeau EA; Newberg JY; Kodama M; Rangel R; Yoshihara K; Ward JM; Jenkins NA; Copeland NG
Gastroenterology; 2016 Aug; 151(2):324-337.e12. PubMed ID: 27178121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
